advertisement
 

  Back to News Research News and Information

Current Research News

    15 August 2018

  1. [New!] Fasting hypoglycemia is associated with disease progression in presymptomatic early stage type 1 diabetes.
  2. [New!] Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 Diabetes.
  3. [New!] Current epidemiology of diabetic retinopathy in patients with type 1 diabetes: a national multicenter study in Brazil. Free full text available in PDF format.
  4. [New!] Studies Unable to Reproduce Results of Two Diabetes Papers.
  5. [New!] A Mathematical Model of Type 1 Diabetes Involving Leptin Effects on Glucose Metabolism.

    8 August 2018

  6. Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.
  7. Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes.
  8. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.
  9. Persistent Elevations in Circulating INS DNA Among Subjects with Longstanding Type 1 Diabetes.
  10. Parental smoking and risk of childhood-onset type 1 diabetes.
  11. Multiresponsive Supramolecular Theranostic Nanoplatform Based on Pillar[5]arene and Diphenylboronic Acid Derivatives for Integrated Glucose Sensing and Insulin Delivery.

    1 August 2018

  12. Closed-Loop Driven by Control-to-Range Algorithm Outperforms Threshold-Low-Glucose-Suspend Insulin Delivery on Glucose Control Albeit not on Nocturnal Hypoglycemia in Pre-pubertal Patients with Type 1 Diabetes in Supervised Hotel Setting.
  13. Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes.
  14. Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program.
  15. The Future of Islet Transplantation Is Now. Free full text available in HTML and PDF formats.

    25 July 2018

  16. Antibiotic-induced acceleration of type 1 diabetes alters maturation of innate intestinal immunity. Full text PDF available via link. See also Changes in bacterial mix linked to antibiotics increase risk for type 1 diabetes.
  17. Qualitative study of barriers to clinical trial retention in adults with recently diagnosed type 1 diabetes. Free full text available in HTML and PDF formats.
  18. Pet exposure in the family during pregnancy and risk for Type 1 diabetes - the prospective ABIS-study.
  19. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications.

    19 July 2018

  20. Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses.
  21. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
  22. Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes.

    4 July 2018

  23. Efficacy and safety of the artificial pancreas in the paediatric population with type 1 diabetes. Free full text available in HTML and PDF formats.
  24. Improving the Safety and Functionality of an Artificial Pancreas System for Use in Younger Children: Input from Parents and Physicians.
  25. Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise.
  26. Adaptability of Closed Loop During Labor, Delivery, and Postpartum: A Secondary Analysis of Data from Two Randomized Crossover Trials in Type 1 Diabetes Pregnancy. Free full text available in HTML and PDF formats.

    27 June 2018

  27. Safety and Performance of the Omnipod® Hybrid Closed-Loop System in Children Aged 6-12 Years with Type 1 Diabetes over Five Days Under Free-Living Conditions.
  28. Impact of macronutrient content of meals on postprandial glucose control in the context of closed-loop insulin delivery - a randomized cross-over study.
  29. Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study.
  30. Ultra-rapid BioChaperone Lispro Improves post-prandial Blood Glucose Excursions versus Insulin Lispro in a 14-day crossover Treatment Study in Patients with Type 1 Diabetes.
  31. HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study.
  32. Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations. Free full text available in PDF format. See also Joint Statement from JDRF and the American Diabetes Association.

    20 June 2018

  33. Challenges to Reshape the Future of Type 1 Diabetes Research.

    13 June 2018

  34. C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase. See also New hope from the 'seven year switch' in Type 1 diabetes.
  35. Antibiotics, acetaminophen and infections during prenatal and early life in relation to type 1 diabetes.
  36. New Horizons in the Treatment of Type 1 Diabetes: More Intense Immunosuppression and Beta Cell Replacement. Free full text available in HTML and PDF formats.

    6 June 2018

  37. Insulin-producing Cells from Adult Human Bone Marrow Mesenchymal Stromal Cells Could Control Chemically Induced Diabetes in Dogs: A Preliminary Study.
  38. Type 1 Diabetes Mellitus in Saudi Arabia: A Soaring Epidemic. Free full text available in HTML and PDF formats.
  39. Frequent Monitoring of C-peptide Levels in Newly Diagnosed Type 1 Subjects Using Dried Blood Spots Collected at Home.
  40. Sex as a determinant of type 1 diabetes at diagnosis.

    23 May 2018

  41. Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis. Free full text available in HTML and PDF formats.
  42. Intake of polyunsaturated fatty acids and risk of preclinical and clinical type 1 diabetes in children-a systematic review and meta-analysis.
  43. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.
  44. Assessment of porcine endogenous retrovirus transmission across an alginate barrier used for the encapsulation of porcine islets.

    16 May 2018

  45. Influence of early-life parental severe life events on the risk of type 1 diabetes in children: the DiPiS study.
  46. Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
  47. Impact of genetic polymorphism in the β₂-receptor gene on risk of severe hypoglycemia in patients with type 1 diabetes.
  48. The impact of hypoglycaemia awareness status on regional brain responses to acute hypoglycaemia in men with type 1 diabetes.

    9 May 2018

  49. In-home nighttime predictive low glucose suspend experience in children and adults with type 1 diabetes.
  50. Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients With Type 1 Diabetes: Is There an Association? Free full text available in HTML and PDF formats.

    2 May 2018

  51. Factors associated with preservation of C-peptide levels at the diagnosis of type 1 diabetes.
  52. Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice.

    25 April 2018

  53. Higher parental occupational social contact is associated with a reduced risk of incident pediatric type 1 diabetes: Mediation through molecular enteroviral indices. Free full text available in HTML and PDF formats.
  54. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. Free full text available in HTML and PDF formats.
  55. Longitudinal assessment of hippocampus structure in children with Type 1 Diabetes.
  56. Impaired vibrotactile sense in children and adolescents with type 1 diabetes - Signs of peripheral neuropathy.
  57. Pancreatic Beta Cell Death: Novel Potential Mechanisms in Diabetes Therapy. Free full text available in HTML and PDF formats.

    18 April 2018

  58. Prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycaemia in adults with type 1 diabetes in a real‐world setting. Free full text available in PDF format. See also Nasal glucagon safe, effective in treating hypoglycemic events in children at home, school.
  59. Exploring Variation in Glycemic Control Across and Within Eight High-Income Countries: A Cross-Sectional Analysis of 64,666 Children and Adolescents With Type 1 Diabetes.
  60. Plasma Insulin Levels and Hypoglycemia Affect Subcutaneous Interstitial Glucose Concentration.
  61. Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.
  62. Persistence of abnormalities in white matter in children with type 1 diabetes.
  63. Study finds high rates of type 1 diabetes near food swamps.
  64. GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia.

    4 April 2018

  65. Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children. See also Genes can help predict children's risk of type 1 diabetes.
  66. The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System.
  67. Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality - United States, 2000-2014. Free full text available in HTML and PDF formats.

    28 March 2018

  68. Economic Costs of Diabetes in the U.S. in 2017. Free full text available in PDF format.
  69. Automated Insulin Delivery Systems: Hopes and Expectations of Family Members.
  70. Hypoglycaemia Incidence and Recovery During Home Use of Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
  71. Integration of Routine Parameters of Glycemic Variability in a Simple Screening Method for Partial Remission in Children with Type 1 Diabetes. Free full text available in HTML and PDF formats.
  72. Vitamin D Status, enterovirus infection, and type 1 diabetes in italian children/adolescents.
  73. Family adjustment to diabetes diagnosis in children: Can participation in a study on type 1 diabetes genetic risk be helpful?
  74. Self-reported color-race and genomic ancestry in an admixed population: a contribution of a nationwide survey in patients with type 1 diabetes in Brazil.

    21 March 2018

  75. Unannounced Meals in the Artificial Pancreas: Detection Using Continuous Glucose Monitoring. Free full text available in HTML and PDF formats.
  76. Peptide Immunotherapy for Type 1 Diabetes-Clinical Advances. Free full text available in HTML and PDF formats.
  77. Superior Glycemic Control with a Glucose-Responsive Insulin Analog: Hepatic and Nonhepatic Impacts.
  78. Viral insulin-like peptides activate human insulin and IGF-1 receptor signaling: A paradigm shift for host–microbe interactions. See also Insulin Goes Viral?

    14 March 2018

  79. A phase 3 multicenter, open-label, prospective study designed to evaluate the effectiveness and ease of use of nasal glucagon in the treatment of moderate and severe hypoglycemia in children and adolescents with type 1 diabetes in the home or school setting.
  80. Paracrine Interactions within the Pancreatic Islet Determine the Glycemic Set Point. See also Researchers Confirm Entire Islet Organ is the Master Regulator of Blood Glucose Levels.
  81. α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes.
  82. Adrenaline and cortisol levels are lower during nighttime than daytime hypoglycaemia in children with type 1 diabetes.

    7 March 2018

  83. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. See also Diabetes is actually five separate diseases, research suggests.
  84. A prospective study evaluating the use of nasal glucagon for the treatment of moderate to severe hypoglycemia in adults with type 1 diabetes in a real-world setting.
  85. Seasonal Variation in Month of Diagnosis of Polish Children with Type 1 Diabetes - A Multicenter Study.
  86. Preventing Nocturnal Hypoglycemia: Single- vs Dual-Hormone Artificial Pancreas System.
  87. Safety and Efficacy of Epigenetically Converted Human Fibroblasts Into Insulin-Secreting Cells: A Preclinical Study.

    28 February 2018

  88. Clustering of microvascular complications in Type 1 diabetes mellitus.
  89. Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy.

    21 February 2018

  90. A plateau in new onset type 1 diabetes: Incidence of pediatric diabetes in the United States Military Health System.
  91. Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes. Free full text available in PDF format. See also Researchers find existing drug effective at preventing onset of type 1 diabetes.
  92. Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiota. See also Researchers discover link between gut and type 1 diabetes.
  93. Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System.

    14 February 2018

  94. Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial.
  95. Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycaemia in T1D.
  96. Beta Cell Function after Intensive Subcutaneous Insulin Therapy or Intravenous Insulin Infusion at Onset of T1D in Children without ketoacidosis.
  97. A type 1 diabetes genetic risk score can discriminate monogenic autoimmunity with diabetes from early-onset clustering of polygenic autoimmunity with diabetes.
  98. Administration of vitamin D and high dose of omega 3 to sustain remission of type 1 diabetes.
  99. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes..
  100. Virus-like infection induces human β cell dedifferentiation.

    7 February 2018

  101. Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
  102. Hypoglycemia unawareness in type 1 diabetes suppresses brain responses to hypoglycemia.
  103. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.

    31 January 2018

  104. Excess Mortality in Patients With Type 1 Diabetes Without Albuminuria—Separating the Contribution of Early and Late Risks.
  105. Type 1 Diabetes in Parents and Risk of Attention Deficit Hyperactivity Disorder in Offspring: A Population-Based Study in Sweden.
  106. Soft, smart contact lenses with integrations of wireless circuits, glucose sensors, and displays.

    24 January 2018

  107. Decreased α-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: An analysis based on the nPOD repository. Free full text available in HTML and PDF formats.
  108. Dual-hormone artificial pancreas: benefits and limitations compared with single-hormone systems.
  109. Low-grade Inflammatory Marker Profile May Help to Differentiate Patients With LADA, Classic Adult-Onset Type 1 and Type 2 Diabetes.

    17 January 2018

  110. Early Infant Diet and Islet Autoimmunity in the TEDDY Study.
  111. Incidence of type 1 diabetes in China, 2010-13: population based study. See also Type 1 Diabetes on the Rise in China, Most New Cases in Adults.
  112. Incidence of childhood onset type 1 diabetes in Western Australia from 1985 to 2016: Evidence for a plateau.
  113. Basal Insulin Peglispro Increases Lipid Oxidation, Metabolic Flexibility, Thermogenesis And Ketone Bodies Compared To Insulin Glargine In Subjects With Type 1 Diabetes Mellitus.
  114. Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): a 52-week, randomized, treat-to-target, phase 3 trial.

    10 January 2018

  115. Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial. See also Modifying baby formula doesn't prevent type 1 diabetes in children.
  116. Infant Feeding in Relation to the Risk of Advanced Islet Autoimmunity and Type 1 Diabetes in Children With Increased Genetic Susceptibility: A Cohort Study.
  117. Endogenous Reprogramming of Alpha Cells into Beta Cells, Induced by Viral Gene Therapy, Reverses Autoimmune Diabetes.
  118. Reversible retinal vessel closure from VEGF-induced leukocyte plugging.
  119. Method may reverse vision loss from diabetes.
  120. Incidence of type 1 diabetes in China, 2010-13: population based study. Free full text available in HTML and PDF formats.

    3 January 2018

  121. Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study. Free full text available in HTML and PDF formats.
  122. Effect of a Glucagon Receptor Antibody (REMD-477) in Type 1 Diabetes: A Randomized Controlled Trial.
  123. Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas β Air to Patients with Type 1 Diabetes Mellitus.
  124. Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes. See also Spider web inspired implantable "string" could control diabetes.
  125. Incidence and prevalence trends of youth-onset type 2 diabetes in a cohort of Canadian youth: 2002-2013.

    27 December 2017

  126. Pharmacokinetic and Pharmacodynamic Characteristics of Dasiglucagon, a Novel Soluble and Stable Glucagon Analog.
  127. Coxsackievirus-Induced Proteomic Alterations in Primary Human Islets Provide Insights for the Etiology of Diabetes. Free full text available in HTML and PDF formats.
  128. Plasma immunological markers in pregnancy and cord blood: A possible link between macrophage chemo-attractants and risk of childhood type 1 diabetes.
  129. Body Mass Index and Incident Type 1 and Type 2 Diabetes in Children and Young Adults: A Retrospective Cohort Study.
  130. Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story.
  131. Primary outcomes reporting in trials of paediatric type 1 diabetes mellitus: a systematic review. Free full text available in HTML and PDF formats.

    20 December 2017

  132. Assessment of preservation of beta-cell function in children with long-standing type 1 diabetes with "ultrasensitive c-peptide" method.
  133. Glucose-Stimulated Insulin Response of Silicon Nanopore-Immunoprotected Islets under Convective Transport.
  134. The KL-VS polymorphism of KLOTHO gene is protective against retinopathy incidence in patients with type 1 diabetes.
  135. Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data.
  136. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review.

    13 December 2017

  137. Microvascular Complications in Type 1 Diabetes: A Comparative Analysis of Patients Treated with Autologous Nonmyeloablative Hematopoietic Stem-Cell Transplantation and Conventional Medical Therapy. Free full text available in HTML and PDF formats.
  138. The Folate Cycle As a Cause of Natural Killer Cell Dysfunction and Viral Etiology in Type 1 Diabetes. Free full text available in HTML and PDF formats.
  139. Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study. Free full text available in HTML and PDF formats.
  140. The association between asthma and type 1 diabetes: a paediatric case-cohort study in Finland, years 1981-2009.
  141. Simultaneous Pancreas and Kidney Transplantation is Associated With Inferior Long-Term Outcomes in African Americans.

    6 December 2017

  142. HLA and non-HLA genes and familial predisposition to autoimmune diseases in families with a child affected by type 1 diabetes. Free full text available in HTML and PDF formats.
  143. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Free full text available in HTML and PDF formats.
  144. The proportion of familial cases of type 1 diabetes is increasing simultaneously with the disease incidence: Eighteen years of the Israeli Pediatric Diabetes Registry.
  145. Childhood Antibiotic Use Not Linked to Islet or Celiac Disease Autoimmunity. (References Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity, previously reported.)
  146. Artificial Pancreas Device Systems for the Closed-Loop Control of Type 1 Diabetes: What Systems Are in Development? Free full text available in HTML and PDF formats.
  147. Synthetic "smart gel" provides glucose-responsive insulin delivery in diabetic mice.
  148. Researchers Pit Mini-dose Glucagon Vs. Carbs to Treat Lows.

    29 November 2017

  149. Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents.
  150. The role of enterovirus infections in type 1 diabetes in Tunisia.
  151. The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1.
  152. Safety and efficacy of autoantigen-specific therapy with 2 doses of alum-formulated glutamate decarboxylase in children with multiple islet autoantibodies and risk for type 1 diabetes: A randomized clinical trial.
  153. The Distribution of Different Types of Diabetes on Childhood: A Single Center Experience.
  154. Dynamic changes in retinal vessel diameter during acute hyperglycemia in type 1 diabetes.

    22 November 2017

  155. Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes.
  156. Preserved Proinsulin Secretion in Long Standing Type 1 Diabetes.
  157. Impact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
  158. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes. See also Enterovirus vaccine prevents virus-induced diabetes in a T1D experimental model.
  159. N-Glycan Profile and Kidney Disease in Type 1 Diabetes.

    15 November 2017

  160. Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study. Free full text available in HTML and PDF formats.
  161. Screening for Type 1 Diabetes Risk in Newborns: The Freder1k Pilot Study in Saxony.
  162. Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients’ Age and Disease Duration. Free full text available in HTML and PDF formats.
  163. Enterovirus-associated changes in blood transcriptomic profiles of children with genetic susceptibility to type 1 diabetes.
  164. 25-hydroxyvitamin D, autoantigenic and total antibody concentrations: results from a Danish case-control study of newly diagnosed patients with childhood type 1 diabetes and their healthy siblings.
  165. Associations between birthweight, gestational age at birth and subsequent type 1 diabetes in children under 12: a retrospective cohort study in England, 1998-2012.
  166. A novel curcumin derivative for the treatment of diabetic neuropathy.

    8 November 2017

  167. Impact of an Automated Bihormonal Delivery System on Psychosocial Outcomes in Adults with Type 1 Diabetes.
  168. The Role of Age and Excess Body Mass Index in Progression to Type 1 Diabetes in At-Risk Adults.
  169. Maternal obesity as a risk factor for early childhood type 1 diabetes: a nationwide, prospective, population-based case-control study.
  170. Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort.
  171. Factors Affecting Recruitment of Participants for Studies of Diabetes Technology in Newly Diagnosed Youth with Type 1 Diabetes: A Qualitative Focus Group Study with Parents and Children. Free full text available in HTML and PDF formats.

    1 November 2017

  172. Synthetic beta cells for fusion-mediated dynamic insulin secretion. See also Smart artificial beta cells could lead to new diabetes treatment.
  173. On the etiology of type 1 diabetes: Physiological growth in children impacts disease progression.
  174. Time trends, regional variability and seasonality regarding the incidence of type 1 diabetes mellitus in Romanian children aged 0-14 years, between 1996 and 2015.
  175. Incidence, prevalence, and seasonal onset variation of Addison's disease among persons with type 1 diabetes mellitus: nationwide, matched, cohort studies.

    25 October 2017

  176. Association Between Early-Life Antibiotic Use and the Risk of Islet or Celiac Disease Autoimmunity.
  177. What End Users and Stakeholders Want From Automated Insulin Delivery Systems.
  178. Incidence, Demographics, and Clinical Characteristics of Diabetes of the Exocrine Pancreas (Type 3c): A Retrospective Cohort Study. See also Newly-identified third type of diabetes is being wrongly diagnosed as type 2.
  179. Optical coherence tomography angiography vessel density in children with type 1 diabetes. Free full text available in HTML and PDF formats.
  180. Pre-clinical results in pig-to-non-human primate islet xenotransplantation using anti-CD40 antibody (2C10R4)-based immunosuppression.

    18 October 2017

  181. Low Incidence of End-Stage Renal Disease in Childhood-Onset Type 1 Diabetes Followed for Up to 42 Years.
  182. Acceptability of Implantable Continuous Glucose Monitoring Sensor.
  183. Factors Associated with C-peptide Levels after Diagnosis in Children with Type 1 Diabetes Mellitus. Free full text available in HTML and PDF formats.
  184. Markers influencing the presence of partial clinical remission in patients with newly diagnosed type 1 diabetes.
  185. 12-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia.
  186. Type 1 Diabetes and Impaired Awareness of Hypoglycemia Are Associated with Reduced Brain Gray Matter Volumes. Free full text available in HTML and PDF formats.
  187. Early-Life Nutritional Factors and Mucosal Immunity in the Development of Autoimmune Diabetes.
  188. Coxsackievirus B4 as a Causative Agent of Diabetes Mellitus Type 1: Is There a Role of Inefficiently Treated Drinking Water and Sewage in Virus Spreading?

    10 October 2017

  189. Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children. Free full text available in PDF format. See also The risk of type 1 diabetes not increased by swine flu vaccine Pandemrix.
  190. Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine.
  191. The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age.
  192. Association of glycemic control with reduced risk of large vessel disease after more than 50 years of type 1 diabetes.

    4 October 2017

  193. The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes.
  194. In Silico Modeling of Minimal Effective Insulin Doses Using the UVA/PADOVA Type 1 Diabetes Simulator.

    27 September 2017

  195. T1D Risk Increased Following Influenza A H1N1 Diagnosis in Children.
  196. Childhood body mass index in relation to subsequent risk of type 1 diabetes-A Danish cohort study.
  197. Beta Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells.
  198. Nitrate induces a type 1 diabetic profile in alligator hatchlings.

    20 September 2017

  199. Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
  200. Vitamin D and probiotics supplement use in young children with genetic risk for type 1 diabetes.
  201. Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trial.
  202. Pandemic influenza diagnosis and subsequent risk of type 1 diabetes. See also Pandemic Flu May Increase Risk of Type 1 Diabetes In Genetically Predisposed Patients.

    13 September 2017

  203. Helicobacter pylori Infection Is Associated with Type 2 Diabetes, Not Type 1 Diabetes: An Updated Meta-Analysis. Free full text available in HTML and PDF formats.
  204. Incidence trends of type 1 diabetes before and after the reunification in children up to 14 years of age in Saxony, Eastern Germany. Free full text available in HTML and PDF formats.
  205. Severe Hypoglycemia-Induced Fatal Cardiac Arrhythmias are Augmented by Diabetes and Attenuated by Recurrent Hypoglycemia.

    6 September 2017

  206. Protective major histocompatibility complex allele prevents type 1 diabetes by shaping the intestinal microbiota early in ontogeny. See also Role Of Gut Bacteria In Averting Type 1 Diabetes.
  207. Improving the Safety and Functionality of an Artificial Pancreas System for Use in Younger Children: Input from Parents and Physicians.
  208. Albuminuria Reduction after High Dose of Vitamin D in Patients with Type 1 Diabetes Mellitus: A Pilot Study. Free full text available in HTML and PDF formats.
  209. Type 1 diabetes incidence and prevalence trends in a cohort of Canadian children and youth..
  210. Excess all-cause mortality before age 30 in childhood onset type 1 diabetes: data from the Brecon Group Cohort in Wales.
  211. Live attenuated enterovirus vaccine (OPV) is not associated with islet autoimmunity in children with genetic susceptibility to type 1 diabetes: prospective cohort study.

    30 August 2017

  212. What End Users and Stakeholders Want From Automated Insulin Delivery Systems.
  213. Closed Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study.
  214. Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.
  215. Untargeted metabolomic analysis in naturally occurring canine diabetes mellitus identifies similarities to human Type 1 Diabetes.
  216. Venous, Arterialized-Venous, or Capillary Glucose Reference Measurements for the Accuracy Assessment of a Continuous Glucose Monitoring System.

    23 August 2017

  217. Reprogramming human gallbladder cells into insulin-producing β-like cells. Free full text available in HTML and PDF formats.
  218. Efficacy and safety of Biosimilar (SAR342434 insulin lispro) in adults with type 1 diabetes also using insulin glargine-SORELLA 1 study. Free full text available in PDF format. See also Biosimilar of Humalog Shows Non-Inferiority in Type 1 Diabetes.
  219. Attenuated Suppression of Lipolysis Explains Increases in Triglyceride Secretion and Concentration with Basal Insulin Peglispro (BIL) Relative to Insulin Glargine Treatment in Patients with Type 1 Diabetes.
  220. Single Dose Euglycemic Clamp Studies Demonstrating Pharmacokinetic and Pharmacodynamic Similarity Between MK-1293 Insulin Glargine and Originator Insulin Glargine (Lantus) in Type 1 Diabetes and Healthy Subjects.
  221. Detection of Islet Cell Immune Reactivity with Low Glycemic Index Foods: Is This a Concern for Type 1 Diabetes? Free full text available in HTML and PDF formats.

    16 August 2017

  222. Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes. Free full text available in PDF format. See also Pioneering type 1 diabetes therapy safe.

    9 August 2017

  223. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study.
  224. Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.
  225. Efficacy and Safety of Relamorelin in Diabetics with Symptoms of Gastroparesis: A Randomized, Placebo-Controlled Study.
  226. Induction of IAPP amyloid deposition and associated diabetic abnormalities by a prion-like mechanism. Free full text available in PDF format. See also Could diabetes spread like mad cow disease?

    2 August 2017

  227. Bolusing frequency and amount impacts glucose control during hybrid closed-loop.
  228. Fog Computing and Edge Computing Architectures for Processing Data From Diabetes Devices Connected to the Medical Internet of Things.
  229. Patterns of Early-Life Gut Microbial Colonization during Human Immune Development: An Ecological Perspective. Free full text available in HTML and PDF formats.

    26 July 2017

  230. Predictors of early renal function decline in adults with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes and the Pittsburgh Epidemiology of Diabetes Complications studies.
  231. Efficacy and safety of Biosimilar (SAR342434 insulin lispro) in adults with type 1 diabetes also using insulin glargine-SORELLA 1 study.
  232. Beyond glycemic control: a cross-over, double-blind, 24 week intervention with liraglutide in type 1 diabetes.

    19 July 2017

  233. Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children.
  234. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol. Free full text available in HTML and PDF formats.
  235. Anti-IL-21 monoclonal antibody combined with liraglutide effectively reverses established hyperglycemia in mouse models of type 1 diabetes.
  236. Nasal Glucagon Fixes Severe Hypoglycemia in Type 1 Diabetes.

    12 July 2017

  237. My Child Is Islet Autoantibody Positive: Impact on Parental Anxiety.
  238. Occupation with grain crops is associated with lower type 1 diabetes incidence: Registry-based case-control study. Free full text available in PDF format.
  239. Overnight Closed Loop Control Improves Glycemic Control in a Multicenter Study of Adults with Type 1 Diabetes.
  240. The Challenges of Achieving Postprandial Glucose Control using Closed-Loop Systems in Patients with Type 1 Diabetes.
  241. Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children. See also Type 1 diabetes risk linked to intestinal viruses.

    28 June 2017

  242. Extensive Assessment of Blood Glucose Monitoring During Postprandial Period and Its Impact on Closed-Loop Performance.
  243. Genetic and Environmental Interactions Modify the Risk of Diabetes-Related Autoimmunity by 6 Years of Age: The TEDDY Study.
  244. Effects of Type 1 Diabetes Risk Alleles on Immune Cell Gene Expression. Free full text available in HTML and PDF formats.
  245. β-Cell Replacement Strategies: The Increasing Need for a “β-Cell Dogma”. Free full text available in HTML and PDF formats.

    21 June 2017

  246. Oral insulin therapy fails to prevent type 1 diabetes, but some see disease delay.
  247. Racial and ethnic differences among children with new-onset autoimmune Type 1 diabetes.
  248. Retinal Ganglion Cell Loss in Children With Type 1 Diabetes Mellitus Without Diabetic Retinopathy.
  249. Seasonality and autoimmune diseases: The contribution of the four seasons to the mosaic of autoimmunity.

    14 June 2017

  250. Stability, Accuracy, and Risk Assessment of a Novel Subcutaneous Glucose Sensor.
  251. Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk.
  252. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.

    7 June 2017

  253. Bioengineering of an Intraabdominal Endocrine Pancreas. Free full text available in PDF format.
  254. 'Artificial Pancreas' Coming Soon for Diabetes Patients.
  255. Closed-Loop Insulin Delivery for Adults with Type 1 Diabetes Undertaking High-Intensity Interval Exercise Versus Moderate-Intensity Exercise: A Randomized, Crossover Study.
  256. Analyzing breath samples of hypoglycemic events in type 1 diabetes patients: towards developing an alternative to diabetes alert dogs.
  257. Clinical Impact of Blood Glucose Monitoring Accuracy: An In-Silico Study.

    31 May 2017

  258. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.
  259. "It is Definitely a Game Changer": A Qualitative Study of Experiences with In-home Overnight Closed-Loop Technology Among Adults with Type 1 Diabetes.
  260. Mortality in type 1 diabetes diagnosed in childhood in Northern Ireland during 1989-2012: A population-based cohort study.
  261. Ketoacidosis at diagnosis of type 1 diabetes: Effect of prospective studies with newborn genetic screening and follow up of risk children.
  262. Markers of immune-mediated inflammation in the brains of young adults and adolescents with type 1 diabetes and fatal diabetic ketoacidosis. Is there a difference?
  263. Comparative Pathogenesis of Autoimmune Diabetes in Humans, NOD Mice, and Canines: Has a Valuable Animal Model of Type 1 Diabetes Been Overlooked?

    24 May 2017

  264. Development of glucose-responsive 'smart' insulin systems.
  265. Impact of age and antibody type on progression from single to multiple autoantibodies in type 1 diabetes relatives.
  266. Sodium-Glucose Co-transporter-2 Inhibitors and Diabetic Ketoacidosis. An Updated Review of the Literature.

    17 May 2017

  267. Infant Feeding and Risk of Type 1 Diabetes in Two Large Scandinavian Birth Cohorts.
  268. A Review of the Current Challenges Associated with the Development of an Artificial Pancreas by a Double Subcutaneous Approach.
  269. Study: Artificial pancreas helps young children better control their diabetes.
  270. The Impact of Diet Wheat Source on the Onset of Type 1 Diabetes Mellitus-Lessons Learned from the Non-Obese Diabetic (NOD) Mouse Model. Free full text available in HTML and PDF formats.
  271. Glucose Peaks and the Risk of Dementia and 20-Year Cognitive Decline.
  272. Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade.
  273. A1 beta-casein milk protein and other environmental pre-disposing factors for type 1 diabetes.

    10 May 2017

  274. Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity.
  275. Intraperitoneal Insulin Delivery Provides Superior Glycemic Regulation to Subcutaneous Insulin Delivery in Model Predictive Control-based Fully-automated Artificial Pancreas in Patients with Type 1 Diabetes: A Pilot Study.
  276. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
  277. Heterogeneity of Type 1 Diabetes: The Effect of Ethnicity.

    3 May 2017

  278. Dog Exposure During the First Year of Life and Type 1 Diabetes in Childhood. See also Man's Best Friend Fails to Protect Against Type 1 Diabetes.
  279. Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control.
  280. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
  281. A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes. Free full text available in HTML and PDF formats. See also Predictive tool for children with type 1 diabetes will improve care, avoid complications.
  282. Endocannabinoid system acts as a regulator of immune homeostasis in the gut. Free full text available in HTML and PDF formats. See also Compound in marijuana, chili peppers could reduce gut inflammation in type 1 diabetes.
  283. Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospect. Free full text available in HTML and PDF formats.

    26 April 2017

  284. Can Type 1 diabetes progression be halted? Possible role of high dose vitamin D and omega 3 fatty acids.
  285. Performance of an Artificial Pancreas System for Young Children with Type 1 Diabetes.
  286. Effects of Dapagliflozin on Insulin-requirement, Glucose Excretion, and ß- Hydroxybutyrate levels are not related to Baseline HbA1c in Youth with Type 1 Diabetes.
  287. Psychiatric medication use before and after the onset of type 1 diabetes in children and adolescents: A population-based cohort study.
  288. Xenotransplantation of layer-by-layer encapsulated non-human primate islets with a specified immunosuppressive drug protocol.

    19 April 2017

  289. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012.
  290. Ethnic differences in association of high body mass index with early onset of Type 1 diabetes – Arab ethnicity as case study. Free full text available in HTML and PDF formats.
  291. Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.
  292. Rotavirus Vaccination and the Risk of Celiac Disease or Type 1 Diabetes in Finnish Children at Early Life.
  293. Metabolomics reveals new metabolic perturbations in children with type 1 diabetes.
  294. Low-calorie sweeteners may allow more glucose to enter fat cells.

    12 April 2017

  295. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. See also ‘Medicinal food’ diet counters onset of type 1 diabetes.
  296. Increased inflammation is associated with islet autoimmunity and type 1 diabetes in the Diabetes Autoimmunity Study in the Young (DAISY). Free full text available in HTML and PDF formats.
  297. Effect of eicosapentaenoic acid and docosahexaenoic acid supplementation on C-peptide preservation in pregnant women with type-1 diabetes: randomized placebo controlled clinical trial.
  298. Virgin Beta Cells Persist throughout Life at a Neogenic Niche within Pancreatic Islets. See also New source of insulin-producing cells discovered for diabetics, A Brand New Type of Insulin-Producing Cell Has Been Discovered Hiding in the Pancreas, and New type of insulin-producing cell discovered.
  299. Single Retinal Layer Evaluation in Patients with Type 1 Diabetes with No or Early Signs of Diabetic Retinopathy: The First Hint of Neurovascular Crosstalk Damage between Neurons and Capillaries?

    29 March 2017

  300. Worm infestations and development of autoimmunity in children - The ABIS study. Free full text available in HTML and PDF formats.
  301. Duodenal mucosa of patients with type 1 diabetes shows distinctive inflammatory profile and microbiota.
  302. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes.
  303. Monogenic Diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes Centers during 2007-2012.
  304. Biomarker found that could help predict the onset of Type 1 diabetes.

    22 March 2017

  305. Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes. Free full text available in HTML and PDF formats.
  306. An analysis of the survival outcomes of simultaneous pancreas and kidney transplantation compared to live donor kidney transplantation in patients with type 1 diabetes: a UK Transplant Registry study.

    15 March 2017

  307. Vaccinations in early life are not associated with development of islet autoimmunity in type 1 diabetes high-risk children: Results from prospective cohort data.
  308. Use of Wearable Sensors and Biometric Variables in an Artificial Pancreas System. Free full text available in HTML and PDF formats.
  309. Meal Detection and Carbohydrate Estimation Using Continuous Glucose Sensor Data.
  310. Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations. Free full text available in HTML and PDF formats.
  311. Association of Skin Intrinsic Fluorescence with Retinal Microvascular Complications of Long Term Type 1 Diabetes in the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
  312. CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success? Free full text available in HTML and PDF formats.

    8 March 2017

  313. Updated 24-year trend of Type 1 diabetes incidence in children in Poland reveals a sinusoidal pattern and sustained increase.
  314. Using in vivo corneal confocal microscopy to identify diabetic sensorimotor polyneuropathy risk profiles in patients with type 1 diabetes. Free full text available in HTML and PDF formats.
  315. Leptin Levels in Patients with Type 1 Diabetes Mellitus After Fetal Pancreatic Stem Cell Transplant.

    1 March 2017

  316. Fasting-Mimicking Diet Promotes Ngn3-Driven β-Cell Regeneration to Reverse Diabetes. Free full text available in HTML and PDF formats. See also Fasting diet 'regenerates diabetic pancreas'.
  317. Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes. See also City of Hope researchers discover new potential cause of type 1 diabetes and and New Theory About the Cause of Type 1 Diabetes.
  318. An Amperometric Glucose Sensor Integrated Into an Insulin Delivery Cannula: In Vitro and In Vivo Evaluation. Free full text available in HTML and PDF formats.
  319. Pleotropic Acute and Chronic Effects of Leptin to Reverse Type 1 Diabetes.

    22 February 2017

  320. Compensatory Hyperconnectivity in Developing Brains of Young Children With Type 1 Diabetes.
  321. Intralymphatic Injection of Autoantigen in Type 1 Diabetes. See also Injection Into Lymph Nodes May Slow Progression of Type 1 Diabetes.
  322. Type 1 Diabetes Candidate Genes Linked to Pancreatic Islet Cell Inflammation and Beta-Cell Apoptosis. Free full text available in HTML and PDF formats.
  323. Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus.
  324. Efficacy and Safety of Metreleptin Therapy in Patients With Type 1 Diabetes: A Pilot Study.

    15 February 2017

  325. Glucose Driven Changes in Beta Cell Identity Are Important for Function and Possibly Autoimmune Vulnerability during the Progression of Type 1 Diabetes. Free full text available in HTML and PDF formats.
  326. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.

    8 February 2017

  327. Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus.
  328. In-vitro evaluation of enteric coated insulin tablets containing absorption enhancer and enzyme inhibitor.

    1 February 2017

  329. Psychosocial effects in parents and children 12 years after newborn genetic screening for type 1 diabetes.
  330. Increase in Pancreatic Proinsulin and Preservation of Beta Cell Mass in Autoantibody Positive Donors prior to Type 1 Diabetes Onset.
  331. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
  332. Residual beta-cell function in diabetes children followed and diagnosed in the TEDDY study compared to community controls.
  333. Interspecies organogenesis generates autologous functional islets. See also Rat-grown mouse pancreases help reverse diabetes in mice.

    25 January 2017

  334. Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study. Free full text available in HTML and PDF formats. See also New artificial pancreas study shows blood sugar improvements in type 1 diabetes.
  335. Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: an open-label, randomised, crossover, controlled trial.
  336. Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes.
  337. Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs). Free full text available in HTML and PDF formats.
  338. Pro-inflammatory Effects of Hypoglycemia in Humans with or without Diabetes.

    18 January 2017

  339. Predictive Hyperglycemia and Hypoglycemia Minimization: In-Home Evaluation of Safety, Feasibility, and Efficacy in Overnight Glucose Control in Type 1 Diabetes.
  340. First Infant Formula Type and Risk of Islet Autoimmunity in The Environmental Determinants of Diabetes in the Young (TEDDY) Study.
  341. Diet Quality during Infancy and Early Childhood in Children with and without Risk of Type 1 Diabetes: A DEDIPAC Study. Free full text available in HTML and PDF via link.
  342. Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept.

    11 January 2017

  343. Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity.
  344. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
  345. Is islet transplantation a realistic approach to curing diabetes? Free full text available in HTML and PDF formats.
  346. "Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus.
  347. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. Free full text available in HTML and PDF formats.

    4 January 2017

  348. Bionic pancreas system successfully controls blood sugar without risk of hypoglycemia reports on Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover tria, previously reported.
  349. Four-year clinical remission of type 1 diabetes mellitus in two patients treated with sitagliptin and vitamin D3. Free full text available in HTML and PDF formats.
  350. The influence of sex on hyperfiltration in patients with uncomplicated type 1 diabetes.
  351. Extending Halogen-based Medicinal Chemistry to Proteins. See also Chemically modified insulin is available more quickly.
  352. Harvard biologist retracts diabetes breakthrough in Cell. See also Retraction Notice to: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation.

[ Current Research News | News from 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]



                 
  Back to News Return to the Top of This Page

Last Updated: Wednesday August 15, 2018 19:56:18
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.